(Overview) Molecular Tumor Board: Resistance to Checkpoint Inhibitors - Part 1 Published 2019-01-29 Download video MP4 360p Recommendations 03:15 (Overview) Molecular Tumor Board: Resistance to Checkpoint Inhibitors Part 2 1:05:36 Part 1 - Molecular and Precision Medicine (MAP) Series 02:06 Signs and Symptoms of a Brain Tumor | Dana-Farber Cancer Institute 02:40 Sexual Function After Prostate Cancer 02:51 Ultra-long-term drug delivery 59:22 Leading as a Surgeon by Day, Writer by Night | Atul Gawande | Voices in Leadership 06:53 Healthcare Finance | MITx on edX 02:54 Expert Chat: What to Know About Sudden Hearing Loss 03:03 (Overview) Targeting Cell Death Pathways with Precision Using Functional Assays 16:48 A New Disease with Far-reaching Implications 04:29 Becoming a Toxicologist 02:41 How long is hernia surgery recovery? 1:01:48 Part 3 - Molecular and Precision Medicine (MAP) Series 06:21 Causes and Treatment of Erectile Dysfunction Video – Brigham and Women’s Hospital 02:28 (Overview) Beyond PARP1: Ribosylation as a Target for Cancer Therapy 01:03 Meet HSCI Co-Director Douglas Melton, PhD 14:46 Excess Deaths at Night - Obstructive Sleep Apnea Explained Clearly 00:55 (Overview) Microfluidics for the Characterization of Tumor-specific Extracellular Vesicles 1:56:10 Sunlight: Optimize Health and Immunity (Light Therapy and Melatonin) 02:34 How is poison ivy treated? Similar videos 01:45 Mechanisms of resistance to checkpoint inhibitors in melanoma 41:46 Molecular Tumor Board 04:56 Molecular Tumor Board - Thoracic ARID1A and PD-L1 present 01:07 Checkpoint inhibitors for lung cancer: combating resistance 58:38 2021 OneOncology | Advancing Precision Oncology in the Community | Molecular Tumor Board 01:37 Resistance to PD-1 Checkpoint Blockade 1:03:18 September 24, 2022, Revolution Cancer International Molecular Tumor Board- NOVARTIS, MET, mdm2, MSI 47:00 Frontiers in Oncology - Antoni Ribas, MD, PhD 27:44 Immune checkpoint blockade in cancer therapy 53:09 Frontiers in Oncology - Michael Lim, MD 58:49 Curing metastatic solid tumours with immune checkpoint inhibitors by Professor James Larkin 40:33 Challenges to Precision Medicine for Anti-Cancer Immunotherapy 03:15 Molecular tumor boards for personalized medicine 06:18 EN - The molecular tumour board 56:36 Public Lecture: Immunotherapy & Cancer - The latest research 44:15 June 7, 2021 | Investigating Mechanisms of Response & Resistance to Immune Checkpoint Therapy 02:05 Immunotherapy resistance mechanisms and predicting NMIBC patient immune responses. 01:27 Analyzing the Role of Checkpoint Inhibitors for the Treatment of Melanoma 55:40 Yale Cancer Center Grand Rounds | December 1, 2020 More results